PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,035,631 | +288.0% | 4,134,868 | +313.5% | 0.42% | +180.5% |
| Q4 2022 | $1,040,000 | -78.1% | 1,000,000 | -75.8% | 0.15% | -76.9% |
| Q3 2022 | $4,755,000 | -38.5% | 4,134,868 | 0.0% | 0.65% | -46.4% |
| Q2 2022 | $7,732,000 | -38.3% | 4,134,868 | 0.0% | 1.21% | -25.4% |
| Q1 2022 | $12,529,000 | +382.3% | 4,134,868 | +501.5% | 1.62% | +521.5% |
| Q4 2021 | $2,598,000 | -32.1% | 687,412 | -7.1% | 0.26% | -56.4% |
| Q3 2021 | $3,826,000 | +197.7% | 740,000 | +48.0% | 0.60% | +156.9% |
| Q1 2021 | $1,285,000 | +2.8% | 500,000 | 0.0% | 0.23% | +40.6% |
| Q4 2020 | $1,250,000 | +20.8% | 500,000 | 0.0% | 0.16% | -69.9% |
| Q3 2020 | $1,035,000 | – | 500,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |